A recent filing submitted to the U.S. Securities and Exchange Commission (SEC) reveals that Connecticut-based fund Braidwell initiated a new position in the digital health platform Hinge Health (HNGE) during the third quarter, purchasing over 910,000 shares. Based on the stock price at the end of the quarter, this position is valued at approximately $44.7 million. This move makes Hinge Health account for 1.8% of the fund’s roughly $2.5 billion in reportable U.S. equity assets. While this allocation remains relatively small compared to its top five holdings—such as CAI (9%) and XENE (5.9%)—its early-stage investment in a recently listed company carries significant signaling value. Since its IPO at $32 per share in May, Hinge Health’s stock price has risen by over 40%, significantly outperforming the S&P 500 index during the same period.
This investment by Braidwell Fund is underpinned by recognition of Hinge Health’s strong fundamentals. The company operates as a digital health platform focused on musculoskeletal health, utilizing a Software-as-a-Service (SaaS) model to provide subscription-based solutions to large employers, health insurance companies, and healthcare providers. The latest financial data showcases its rapid expansion: third-quarter revenue increased by 53% year-over-year to $154.2 million; GAAP gross margin improved to 82%; and free cash flow reached a record high of $81.3 million. Meanwhile, its customer base grew by 25%, with lifetime members exceeding 1.5 million. These metrics collectively depict a growing company with strong operating leverage and stable enterprise-level customer relationships.
Hinge Health’s updated full-year performance guidance, including approximately 47% revenue growth and non-GAAP operating profit between $106 million and $108 million, further strengthens market confidence in its near-term growth prospects. The company’s business model, coupled with its positioning in serving corporate health plans, has established certain competitive barriers in the digital health field. However, for long-term investors, a key focus will be whether the company can maintain high-margin growth while continuing to invest in innovative healthcare services, such as artificial intelligence. Additionally, increasing competition in the employer-focused digital health sector and the company’s current valuation level constitute potential risk factors. Braidwell Fund’s establishment of this position reflects its consistent investment philosophy of targeting scalable, high-demand solutions. Nevertheless, Hinge Health’s future path will continue to face dual tests from the market and its operational performance.
